Results 231 to 240 of about 75,903 (304)

Challenges in Adolescent and Adult Males With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

J Clin Endocrinol Metab
Claahsen-van der Grinten HL, Adriaansen BPH, Falhammar H.   +2 more
europepmc   +1 more source

Mental Health Issues Associated With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

J Clin Endocrinol Metab
Sandberg DE, Gardner M, Lapham ZK.
europepmc   +1 more source

Clinical Manifestations and Challenges in Adolescent and Adult Females With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

J Clin Endocrinol Metab
Engberg H, Nordenström A, Hirschberg AL.   +2 more
europepmc   +1 more source

Clinical Manifestations and Treatment Challenges in Infants and Children With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

J Clin Endocrinol Metab
Nokoff NJ, Buchanan C, Barker JM.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical outcomes in 21-hydroxylase deficiency

Current Opinion in Endocrinology, Diabetes & Obesity, 2021
Purpose of review The introduction of synthetic glucocorticoids 70 years ago made survival possible in classic 21-hydroxylase deficiency (21OHD). The currently used glucocorticoid therapy may lead to unphysiological dosing with negative consequencies on health in addition to the problems that may arise due to androgen over ...
Anna, Nordenström, Svetlana, Lajic, Henrik, Falhammar   +2 more
openaire   +2 more sources